AVADEL PHARMACEUTICALS PLC (AVDL) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 169 transactions totaling $13.5M, demonstrating a bearish sentiment with -$2.1M in net insider flow. The most recent transaction on Jul 29, 2025 involved a transaction of 11,000 shares valued at $0.
No significant insider buying has been recorded for AVDL in the recent period.
No significant insider selling has been recorded for AVDL in the recent period.
Based on recent SEC filings, insider sentiment for AVDL is bearish with an Insider Alignment Score of 42/100 and a net flow of -$2.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AVADEL PHARMACEUTICALS PLC (AVDL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading AVDL stock, having executed 169 transactions in the past 90 days. The most active insider is Craig R. Stapleton (Executive), who has made 28 transactions totaling $5.6M.
Get notified when executives and directors at AVDL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | Amin Naseem | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 29, 2025 | J. Ende Eric | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 29, 2025 | Michael Glass Geoffrey | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 29, 2025 | J. Thornton Peter | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 29, 2025 | Palczuk Linda | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 29, 2025 | Anthony Mccamish Mark | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 30, 2024 | Michael Glass Geoffrey | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 30, 2024 | Anthony Mccamish Mark | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 30, 2024 | Amin Naseem | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 30, 2024 | J. Ende Eric | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 30, 2024 | J. Thornton Peter | Executive | Award | 11,000 | $N/A | $0 | |
| Jul 30, 2024 | Palczuk Linda | Executive | Award | 11,000 | $N/A | $0 | |
| Jan 16, 2024 | S. Mchugh Thomas | Executive | Purchase | 2,000 | $14.50 | $29.0K | |
| Dec 28, 2023 | Anthony Mccamish Mark | Executive | Sale | 75,000 | $14.53 | $1.1M | Large10b5-1 |
| Aug 14, 2023 | S. Mchugh Thomas | Executive | Purchase | 2,000 | $14.45 | $28.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 12 | $7.8M | 51.9% |
Purchase(P) | 58 | $5.7M | 37.8% |
Award(A) | 79 | $1.5M | 10.3% |
Gift(G) | 1 | $0 | 0.0% |
Disposition(D) | 19 | $0 | 0.0% |
Insider activity at AVADEL PHARMACEUTICALS PLC shows mixed signals across all time. While $5.7M in purchases indicates some executive confidence,$7.8M in sales balances the picture, resulting in a modest net flow of -$2.1M.28 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Craig R. Stapleton, has transacted $5.6M during this period.